Liang Hu

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Traumatic Brain Injury

Epidermal Growth Factor Receptor

Top Venues

The EMBO journal

This page only lists publications with an associated author ORCID identifier.

Publications

Liang Hu, Shiming Zhang, John Sienkiewicz, Hua Zhou, Robert Berahovich, Jinying Sun, Michael Li, Adrian Ocampo, Xianghong Liu, Yanwei Huang, Hizkia Harto, Shirley Xu, Vita Golubovskaya, Lijun Wu
HER2-CD3-Fc Bispecific Antibody-Encoding mRNA Delivered by Lipid Nanoparticles Suppresses HER2-Positive Tumor Growth. Vaccines 12 (7) (2024)
Liang Hu, Shiming Zhang, John Sienkiewicz, Hua Zhou, Robert Berahovich, Jinying Sun, Michael Li, Adrian Ocampo, Xianghong Liu, Yanwei Huang, Hizkia Harto, Shirley Xu, Vita Golubovskaya, Lijun Wu
HER2-CD3-Fc Bispecific Antibody-Encoding mRNA Delivered by Lipid Nanoparticles Suppresses HER2-Positive Tumor Growth. Vaccines 12 (7) (2024)
Liang Hu, Shiming Zhang, John Sienkiewicz, Hua Zhou, Robert Berahovich, Jinying Sun, Michael Li, Adrian Ocampo, Xianghong Liu, Yanwei Huang, Hizkia Harto, Shirley Xu, Vita Golubovskaya, Lijun Wu
HER2-CD3-Fc Bispecific Antibody-Encoding mRNA Delivered by Lipid Nanoparticles Suppresses HER2-Positive Tumor Growth. Vaccines 12 (7) (2024)
Qinfang Liu, Dong Zhu, Naren Li, Shifan Chen, Liang Hu, Jianzhong Yu, Yulan Xiong
Regulation of LRRK2 mRNA stability by ATIC and its substrate AICAR through ARE-mediated mRNA decay in Parkinson's disease. The EMBO journal (2023)
Liang Hu, Wyatt Brichalli, Naren Li, Shifan Chen, Yaqing Cheng, Qinfang Liu, Yulan Xiong, Jianzhong Yu
Myotubularin functions through actomyosin to interact with the Hippo pathway. EMBO reports 23 (12) (2022)